Kaiser Permanente Northwest
Portland, Oregon, 97227, United States
NCT Number: NCT01033162
The study's aim is to provide information about the clinical and business cases for comprehensive interactive cancer communication systems (ICCS) in the context of real world use for cancer care.
This study will be conducted within the Kaiser Permanente Northwest (KPNW) healthcare system. Outcomes for this study include amount of ICCS use and women's ratings of cancer information competence, perceived social support, and emotional well being. Secondary outcomes will include healthcare utilization, cost-effectiveness, and clinician ratings of healthcare visits.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Portland, Oregon, 97227, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:
Time frame: 12 Months
University of Wisconsin, Madison
Other
Using Technology to Enhance Cancer Communication and Improve Clinical Outcome: Effectiveness of the CHESS Ehealth Cancer Support Intervention in Population-Based Care Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05923177
Primary Breast Cancer
Tomsk, Russia
View Trial DetailsNCT04277338
Breast Diseases, Breast Neoplasms
Tomsk, Russia
View Trial DetailsNCT06954532
Behavior, Breast Diseases
London, United Kingdom
View Trial DetailsNCT04468113
Breast Diseases, Breast Neoplasms
Essen, Germany
View Trial Details